等待开盘 08-27 09:30:00 美东时间
0.000
0.00%
Vor Bio appoints David Zaccardelli, Pharm.D., to its Board of Directors. With over 20 years of biopharmaceutical leadership experience, Dr. Zaccardelli has successfully navigated companies through late-stage development, regulatory approval, and commercial launch. His appointment comes as Vor Bio advances telitacicept, a novel dual-target fusion protein, through global Phase 3 trials for autoimmune diseases. Dr. Zaccardelli's leadership is expect...
07-07 20:01
国内CEM客户体验管理厂商“数字一百”日前宣布与碧桂园服务、保利物业、顺丰物流、中金财富等展开客户体验管理合作。据数字一百介绍,其体验宝CEMPro客户体验管理...
2022-08-25 09:01